Gene · 57697
Papers1,618
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,618
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Head and Neck Cancer in Fanconi Anemia: Clinical Challenges and Molecular Insights into a DNA Repair Disorder. | Cancers (Basel) | 2025 | 40970532 | PubTator, text mining | PubMed |
| Rare Variants Associated With Pediatric Cancer Treatment-Related Second Malignant Neoplasm Risk. | JCO Precis Oncol | 2025 | 40961407 | PubTator, text mining | PubMed |
| Germline Cancer Susceptibility Variants in Patients With Uveal Melanoma. | Pigment Cell Melanoma Res | 2025 | 40956002 | PubTator, text mining | PubMed |
| Selumetinib Treatment in a Neurofibromatosis Type 1 Child With Second Hit Mutation on the NF1 Gene. | Int J Dev Neurosci | 2025 | 40891287 | PubTator, text mining | PubMed |
| Potential role of Fanconi anemia pathway in the pathogenesis of endometrial cancer (Review). | Mol Med Rep | 2025 | 40849815 | PubTator, text mining | PubMed |
| Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women. | Nat Commun | 2025 | 40841357 | PubTator, text mining | PubMed |
| Homozygous FANCM Variant c.5101C>T p.(Gln1701*) in a Patient With Early Onset Breast Cancer, Chemotherapy Toxicity, and Chromosome Fragility: A Case Report. | Cancer Rep (Hoboken) | 2025 | 40832744 | PubTator, text mining | PubMed |
| Genotype-phenotype correlations in biallelic carriers of FANCM protein truncating variants: A systematic literature review. | Mutat Res Rev Mutat Res | 2025 | 40818381 | PubTator, text mining | PubMed |
| Distinct mechanisms underlying extrachromosomal telomere DNA generation in ALT cancers. | Nucleic Acids Res | 2025 | 40795958 | PubTator, text mining | PubMed |
| Cellular adaptations impact the biological activity of naphthalene diimide G-quadruplex ligands in ALT-positive osteosarcoma cells. | Cell Death Dis | 2025 | 40750583 | PubTator, text mining | PubMed |
| Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors. | Orphanet J Rare Dis | 2025 | 40739565 | PubTator, text mining | PubMed |
| Recessive FANCM cancer syndrome with high cancer risks, chemotherapy toxicity, chromosome fragility, and gonadal failure. | Genet Med | 2025 | 40642874 | PubTator, text mining | PubMed |
| Targeting FANCM using the antisense oligonucleotides to treat the ALT-positive cancers. | Mol Ther Nucleic Acids | 2025 | 40503178 | PubTator, text mining | PubMed |
| Potent Cyclic Peptide Inhibitors Disrupt the FANCM-RMI Interaction. | J Med Chem | 2025 | 40479515 | PubTator, text mining | PubMed |
| Structural basis of Fanconi anemia pathway activation by FANCM. | EMBO J | 2025 | 40447800 | PubTator, text mining | PubMed |
| Primary gastric squamous cell carcinoma in a young adult with immunotherapy complications: a case report. | J Gastrointest Oncol | 2025 | 40386611 | PubTator, text mining | PubMed |
| Critical role of alpha spectrin in DNA repair: the importance of μ-calpain and Fanconi anemia proteins. | Exp Biol Med (Maywood) | 2025 | 40375875 | PubTator, text mining | PubMed |
| Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterations. | Br J Haematol | 2025 | 40344211 | PubTator, text mining | PubMed |
| Optical pooled screening for the discovery of regulators of the alternative lengthening of telomeres pathway. | Methods | 2025 | 40324704 | PubTator, text mining | PubMed |
| Germinal mutations among patients with breast cancer in Colombia: is BRCA3 coming? | Ecancermedicalscience | 2025 | 40259910 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57697/papers?page=3